CAS: 1207113-88-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCG-100602 REF: TM-T22062CAS: 1207113-88-9 | 99.58% | 38.00 €~442.00 € | Wed 11 Dec 24 |
 | CCG-100602 REF: 3D-HYB11388CAS: 1207113-88-9 | Min. 95% | To inquire | Wed 15 Jan 25 |
CCG-100602
CAS:1207113-88-9
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).
Formula:
C21H17ClF6N2O2
Purity:
99.58%
Color and Shape:
Solid
Molecular weight:
478.82
Ref: TM-T22062
| 5mg | 38.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 113.00 € | ||
| 50mg | 185.00 € | ||
| 100mg | 298.00 € | ||
| 200mg | 442.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
CCG-100602
CAS:1207113-88-9
CCG-100602 is a small molecule inhibitor that binds to the actin filament and prevents the …
Formula:
C21H17ClF6N2O2
Purity:
Min. 95%
Molecular weight:
478.8 g/mol
Ref: 3D-HYB11388
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
